Testagen (20mg Vial) Dosage Protocol

Overview

Testagen is a synthetic tetrapeptide with the sequence Lys‑Glu‑Asp‑Gly (KEDG), derived from anterior pituitary tissue. Research suggests it modulates endocrine function, particularly the pituitary–gonadal axis, and may normalize thyroid hormone levels and support male reproductive health.

Key Specifications

Vial Size: 20 mg
Reconstitution Volume: 3.0 mL bacteriostatic water
Final Concentration: ~6.67 mg/mL
Administration: Subcutaneous injection
Frequency: Once daily

Dosing Protocol – Standard Gradual Approach

Week Daily Dose Units on Syringe Volume (mL)
1–2 100 mcg 1.5 units 0.015
3–4 150 mcg 2.25 units 0.0225
5–8 200 mcg 3 units 0.03
9–12 250–300 mcg 3.75–4.5 units 0.0375–0.045

Recommended Schedule: Start at 100 mcg daily; increase by approximately 50 mcg every two weeks. Target range is 200–300 mcg daily by weeks 5–12.

Reconstitution Instructions

1. Draw 3.0 mL of bacteriostatic water using a sterile syringe
2. Inject slowly down the vial wall to avoid foaming
3. Gently swirl or roll until dissolved—avoid shaking
4. Label the vial with reconstitution date
5. Refrigerate at 2–8°C (35.6–46.4°F) protected from light

Storage Requirements

Lyophilized (Powder):
– Store at −20°C (−4°F)
– Keep in dry, dark conditions
– Minimize moisture exposure

Reconstituted Solution:
– Refrigerate at 2–8°C (35.6–46.4°F)
– Avoid freeze–thaw cycles
– Allow vials to warm to room temperature before opening

Supplies Needed (Per Protocol Duration)

For 8-Week Protocol

Testagen Vials: 1 vial (~14 mg used)
Insulin Syringes: 56 syringes (30–50 unit recommended)
Bacteriostatic Water: 1 × 10 mL bottle (uses ~3 mL)
Alcohol Swabs: 2 × 100-count boxes (112 swabs needed)

For 12-Week Protocol

Testagen Vials: 2 vials (~25 mg used)
Insulin Syringes: 84 syringes
Bacteriostatic Water: 1 × 10 mL bottle (uses ~6 mL)
Alcohol Swabs: 2 × 100-count boxes (168 swabs needed)

For 16-Week Protocol

Testagen Vials: 2 vials (~36 mg used)
Insulin Syringes: 112 syringes
Bacteriostatic Water: 1 × 10 mL bottle (uses ~6 mL)
Alcohol Swabs: 3 × 100-count boxes (224 swabs needed)

Injection Technique

1. Preparation: Clean vial stopper and injection site with alcohol; allow to dry completely
2. Needle Angle: Insert at 45–90° into subcutaneous tissue
3. Injection Method: Do not aspirate for subcutaneous injections; inject slowly and steadily
4. Site Rotation: Rotate systematically between abdomen (avoiding 2 inches around navel), thighs, and upper arms
5. Needle Gauge: Use 23–25 gauge, ½–⅝ inch needles for comfort
6. Timing: Wait a few seconds before withdrawing the needle

How It Works

“Testagen belongs to a class of short bioregulatory peptides derived from anterior pituitary” extracts. Preclinical research indicates it can influence hormone synthesis and secretion through gene-regulatory mechanisms. Studies in animal models demonstrate potential normalization of thyroid function and modulation of endocrine signaling pathways. No human clinical trials exist; understanding is based on preclinical research.

Potential Benefits (Preclinical Evidence)

– Normalization of thyroid hormone parameters in animal models
– Potential modulation of male reproductive hormones via pituitary pathways
– Support for endocrine balance and pituitary-gonadal axis function

Side Effects & Safety Considerations

Human Safety Data: None available; no published human trials exist
Possible Injection Reactions: Occasional mild redness or itching at injection site
General Guidance: Use sterile, new syringes for each injection; dispose in appropriate sharps container

Lifestyle Recommendations

– Maintain balanced, nutrient-dense diet supporting endocrine health
– Engage in regular physical activity for hormonal balance
– Prioritize 7–9 hours of quality sleep to optimize hormone rhythms
– Manage stress through mindfulness or other techniques to reduce cortisol interference

Important Notes

– Use 30–50 unit insulin syringes for improved accuracy with low-volume doses (≤5 units)
– Rotate injection sites systematically to prevent tissue irritation
– Document daily doses and site rotation for consistency
– Allow reconstituted vials to reach room temperature before opening to reduce condensation

Cycle Information

Duration Options:
– Standard: 8–12 weeks
– Extended: 16 weeks (optional)

Frequency: Once daily subcutaneous injection at consistent time

Disclaimer

This content is for educational and research purposes only and does not constitute medical advice, diagnosis, or treatment. Testagen has not undergone human clinical trials. All information derives from preclinical research. Consult a qualified healthcare professional before beginning any protocol.